Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Telmisartan + Supervised Treadmill Exercise Therapy	30
Overall Study	STARTED	Telmisartan + No Exercise Control Group	29
Overall Study	STARTED	Placebo + Supervised Treadmill Exercise Therapy	28
Overall Study	STARTED	Placebo + No Exercise Control Group	27
Overall Study	COMPLETED	Telmisartan + Supervised Treadmill Exercise Therapy	30
Overall Study	COMPLETED	Telmisartan + No Exercise Control Group	26
Overall Study	COMPLETED	Placebo + Supervised Treadmill Exercise Therapy	24
Overall Study	COMPLETED	Placebo + No Exercise Control Group	25
Overall Study	NOT COMPLETED	Telmisartan + Supervised Treadmill Exercise Therapy	0
Overall Study	NOT COMPLETED	Telmisartan + No Exercise Control Group	3
Overall Study	NOT COMPLETED	Placebo + Supervised Treadmill Exercise Therapy	4
Overall Study	NOT COMPLETED	Placebo + No Exercise Control Group	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02593110/flow